PRIMARY STUDY
Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies
Key Findings: The authors conclude that cannabinoids may improve some autism-related symptoms i.e. problem behaviors, sleep problems, and hyperactivity. However, their efficacy on core symptoms (i.e., socio-communication impairments, restricted interests, or ritualistic behavior) remains to be elucidated.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Italy, Spain
Year of Pub: 2020
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinoid (unspecified), Pharma THC, Pharma THC:CBD, Pharma CBD
Phytocannabinoid Source: Cannabis Flower derived
Chemotype: Chemotype I, Chemotype II, Chemotype III
Route of Administration: Oral (Ingestion)
Citation: Fusar-Poli L, et al. Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies. Brain Sci. 2020; 10:(unknown pages). doi: 10.3390/brainsci10090572
Authors: Fusar-Poli L, Cavone V, Tinacci S, Concas I, Petralia A, Signorelli MS, Díaz-Caneja CM, Aguglia E
